Comparing different approaches for operationalizing subjective cognitive decline: impact on syndromic and biomarker profiles.
Comparing different approaches for operationalizing subjective cognitive decline: impact on syndromic and biomarker profiles.
复制标题
DOI:
10.1038/s41598-021-83428-1
复制
发表时间:
2021-02-23
影响因子:
4.6
通讯作者:
Westman E
中科院分区:
文献类型:
--
作者:
Diaz-Galvan P;Ferreira D;Cedres N;Falahati F;Hernández-Cabrera JA;Ames D;Barroso J;Westman E
Subjective cognitive decline (SCD) has been proposed as a risk factor for future cognitive decline and dementia. Given the heterogeneity of SCD and the lack of consensus about how to classify this condition, different operationalization approaches still need to be compared. In this study, we used the same sample of individuals to compare different SCD operationalization approaches. We included 399 cognitively healthy individuals from a community-based cohort. SCD was assessed through nine questions about memory and non-memory subjective complaints. We applied four approaches to operationalize SCD: two hypothesis-driven approaches and two data-driven approaches. We characterized the resulting groups from each operationalization approach using multivariate methods on comprehensive demographic, clinical, cognitive, and neuroimaging data. We identified two main phenotypes: an amnestic phenotype characterized by an Alzheimer’s Disease (AD) signature pattern of brain atrophy; and an anomic phenotype, which was mainly related to cerebrovascular pathology. Furthermore, language complaints other than naming helped to identify a subgroup with subclinical cognitive impairment and difficulties in activities of daily living. This subgroup also showed an AD signature pattern of atrophy. The identification of SCD phenotypes, characterized by different syndromic and biomarker profiles, varies depending on the operationalization approach used. In this study we discuss how these findings may be used in clinical practice and research.
登录
查看更多内容
影响因子:
2.7
作者:
Falahati F;Ferreira D;Soininen H;Mecocci P;Vellas B;Tsolaki M;Kłoszewska I;Lovestone S;Eriksdotter M;Wahlund LO;Simmons A;Westman E;AddNeuroMed consortium and the Alzheimer’s Disease Neuroimaging Initiative
通讯作者:
AddNeuroMed consortium and the Alzheimer’s Disease Neuroimaging Initiative
影响因子:
4.2
作者:
Ferreira, Daniel;Molina, Yaiza;Barroso, Jose
通讯作者:
Barroso, Jose
影响因子:
5.2
作者:
Cedres, Nira;Ferreira, Daniel;Westman, Eric
通讯作者:
Westman, Eric
影响因子:
9.9
作者:
Busse, A.;Hensel, A.;Riedel-Heller, S. G.
通讯作者:
Riedel-Heller, S. G.
影响因子:
8.3
作者:
Benedictus, Marije R.;van Harten, Argonde C.;van der Flier, Wiesje M.
通讯作者:
van der Flier, Wiesje M.